📣 VC round data is live. Check it out!

Founder Securities Valuation Multiples

Discover Founder Securities' revenue and EBITDA valuation multiples and investment history, alongside public comparables like St James's Place, Cinda Securities, IG Group, GoFintech Quantum and more.

Founder Securities Overview

About Founder Securities

Founder Securities Co Ltd provides financial services. Its business includes securities brokerage, investment banking, consulting, QFII business, securities underwriting and sponsorship, and fund and asset management. It generates the majority of its revenue from the Wealth Management business segment.


Founded

1994

HQ

China

Employees

7.5K

Financials (LTM)

Revenue: $2B
Net Income: $630M

EV

$19B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Founder Securities Financials

Founder Securities reported last 12-month revenue of $2B.

In the same LTM period, Founder Securities generated $630M in net income.

Revenue (LTM)


Founder Securities P&L

In the most recent fiscal year, Founder Securities reported revenue of $2B and net income of $587M.

Founder Securities is profitable as of last fiscal year, with net margin of 38%.

See analyst estimates for Founder Securities
LTMLast FY202320242025202620272028
Revenue$2B$2B$1B$1B$2B
EBIT Margin46%45%--45%
Net Profit$630M$587M$318M$326M$587M
Net Margin38%38%30%28%38%

Financial data powered by Morningstar, Inc.

Founder Securities Stock Performance

Founder Securities has current market cap of $8B, and enterprise value of $19B.

Market Cap Evolution


Founder Securities' stock price is $1.00.

Founder Securities share price decreased by 1.3% in the last 30 days, and by 12.6% in the last year.

Founder Securities has an EPS (earnings per share) of $0.07.

See more trading valuation data for Founder Securities
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$19B$8B-1.3%-1.3%0.8%-12.6%$0.07

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Founder Securities Valuation Multiples

Founder Securities trades at 11.8x EV/Revenue multiple.

See NTM and 2027E valuation multiples for Founder Securities

EV / Revenue (LTM)


Founder Securities Financial Valuation Multiples

As of June 2, 2026, Founder Securities has market cap of $8B and EV of $19B.

Founder Securities has a P/E ratio of 13.1x.

LTMLast FY202320242025202620272028
EV/Revenue11.8x12.4x18.0x16.8x12.4x
EV/EBIT25.4x28.0x--28.0x
P/E13.1x14.1x26.0x25.3x14.1x
EV/FCF-156.6x(15.3x)n/m156.6x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Founder Securities Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Founder Securities Margins & Growth Rates

Founder Securities grew revenue by 17% and net profit by 20% in the last fiscal year.

In the most recent fiscal year, Founder Securities reported net margin of 38%.

See estimated margins and future growth rates for Founder Securities

Founder Securities Margins

Last FY202420252026202720282029
EBIT Margin45%-45%47%
Net Margin38%28%38%39%
FCF Margin8%2%8%-

Founder Securities Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth17%7%35%17%
EBIT Growth24%--24%
Net Profit Growth20%3%80%20%
FCF Growth-(101%)598%-

Data powered by FactSet, Inc. and Morningstar, Inc.

Founder Securities Operational KPIs

Founder Securities' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Access forward-looking KPIs for Founder Securities
LTMLast FY202320242025202620272028
Revenue per Employee-$0.2M---
Opex per Employee-$0.1M---
G&A Expenses to Revenue53%53%13%13%12%
Opex to Revenue-55%71%66%55%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Founder Securities Competitors

Founder Securities competitors include St James's Place, Cinda Securities, IG Group, GoFintech Quantum, Affiliated Managers Group, Janus Henderson, XP Investimentos, F&C Investment Trust, Storebrand and Hulic Co.

Most Founder Securities public comparables operate across Investment Banking, Investment Brokerage and Asset Management.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
St James's Place0.2x7.9x13.0x13.7x
Cinda Securities24.4x---
IG Group4.9x4.7x9.2x10.0x
GoFintech Quantum73.4x-6250.6x-
Affiliated Managers Group5.1x4.8x7.1x9.0x
Janus Henderson1.9x2.0x4.8x5.4x
XP Investimentos4.3x4.1x12.1x12.4x
F&C Investment Trust10.2x---

This data is available for Pro users. Sign up to see all Founder Securities competitors and their valuation data.

Start Free Trial

Investments by Founder Securities

Founder Securities has invested in 4 companies to date.

Latest investment by Founder Securities was on August 4th 2022. Founder Securities invested in Intellective Bio in their $74M Series C round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Founder Securities

Intellective Bio
ChengTech
Guangdong Huayan Robotics Co., Ltd.
MicuRx Pharmaceuticals
Description
Intellective Bio is a biopharmaceutical firm. It specializes in biologics development, commercial production, protein science, cell engineering, cell culture, protein purification, analytical science, and formulation development.
-
Guangdong Huayan Robotics Co., Ltd. manufactures collaborative robots, seven-axis cobots, and automation systems for industrial applications. Formerly Han’s Robot, it rebranded in March 2025 to pursue global market expansion. Shenzhen-headquartered, the firm produces models like the ELITE series with payloads up to 16 kg for tasks in electronics assembly, welding, and logistics. Its products integrate AI vision and force-sensing technologies deployed in factories across Asia and Europe.
MicuRx Pharmaceuticals is a biopharmaceutical company developing novel antibiotics against drug-resistant bacteria, operating under a U.S.-China hybrid model since 2007. Headquartered in San Mateo with Shanghai operations, MicuRx commercializes contezolid in China since 2021 and advances global Phase 3 trials for infections like pneumonia and skin infections.
HQ CountryChinaChinaChinaUnited States
HQ City
Suzhou
Shenzhen
Shenzhen
San Francisco, CA
Deal Date4 Aug 202215 Dec 202125 Jun 202121 Dec 2020
RoundSeries CSeries BSeries BSeries E
Raised$74M$28M$62M$107M
InvestorsCNCB Capital; CTS Capital; Founder Securities; Fuho Capital; Gaorong Capital; Win Harbor CapitalAddor Capital; Founder Securities; Green Pine Capital Partners; Shaanxi Investment Capital; Shanshan Venture CapitalChina Merchants Venture Capital; CNPC Capital Co; Donghai; Founder Securities; Youshan CapitalChina Merchants Group; DT Capital Partners; Founder Securities; Korea Investment Partners; Legend Capital; Yingke Capital; Zhongtai Venture Capital
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Founder Securities investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Founder Securities

When was Founder Securities founded?Founder Securities was founded in 1994.
Where is Founder Securities headquartered?Founder Securities is headquartered in China.
How many employees does Founder Securities have?As of today, Founder Securities has over 7K employees.
Is Founder Securities publicly listed?Yes, Founder Securities is a public company listed on Shanghai Stock Exchange.
What is the stock symbol of Founder Securities?Founder Securities trades under 601901 ticker.
When did Founder Securities go public?Founder Securities went public in 2011.
Who are competitors of Founder Securities?Founder Securities main competitors include St James's Place, Cinda Securities, IG Group, GoFintech Quantum, Affiliated Managers Group, Janus Henderson, XP Investimentos, F&C Investment Trust, Storebrand, Hulic Co.
What is the current market cap of Founder Securities?Founder Securities' current market cap is $8B.
What is the current revenue of Founder Securities?Founder Securities' last 12 months revenue is $2B.
What is the current revenue growth of Founder Securities?Founder Securities revenue growth (NTM/LTM) is 13%.
What is the current EV/Revenue multiple of Founder Securities?Current revenue multiple of Founder Securities is 11.8x.
What is the current net income of Founder Securities?Founder Securities' last 12 months net income is $630M.
How many companies Founder Securities has acquired to date?Founder Securities hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Founder Securities has invested to date?As of June 2026, Founder Securities has invested in 4 companies.
What was the last Founder Securities investment?On 4th August 2022 Founder Securities invested in Intellective Bio, participating in a $74M Series C round, alongside CNCB Capital, CTS Capital, Fuho Capital, Gaorong Capital, and Win Harbor Capital.
In what companies Founder Securities invested in?Founder Securities invested in MicuRx Pharmaceuticals, Intellective Bio, Guangdong Huayan Robotics Co., Ltd., and ChengTech.

See public comps similar to Founder Securities

Lists including Founder Securities

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial